Category: BÜHLMANN Neuroimmunology Assay Citations

Use of Antibody Testing in Nervous System Disorders

Anti-MAG Autoantibodies ELISA Citation: Willison H J et al.; Use of Antibody Testing in Nervous System Disorders – EAN; published in: European Handbook of Neurological Management: Volume 1, 2nd Edition; Edited by N. E. Gilhus, M. P. Barnes and M. Brainin; © 2011 Blackwell Publishing Ltd. ISBN: 978-1-405-18533-2.  

Continue Reading

Neurophysiological and Clinical Responses to Rituximab in Patients with Anti-MAG Polyneuropathy

Anti-MAG Autoantibodies ELISA Citation: Zara G et al.; Neurophysiological and clinical responses to rituximab in patients with anti-MAG polyneuropathy. Clin Neurophysiol. 2011 Dec; 122(12): 2518-22. PMID:21680240

Continue Reading

Rapid Worsening of IgM Anti-MAG Demyelinating Polyneuropathy During Rituximab Treatment

Anti-MAG Autoantibodies ELISA Citation: Stork AC et al.; Rapid worsening of IgM anti-MAG demyelinating polyneuropathy during rituximab treatment. J Peripher Nerv Syst. 2013 Jun; 18(2):189-91. PMID:23781968

Continue Reading

Acute Neurological Worsening After Rituximab Treatment in Patients with Anti-MAG Neuropathy

Anti-MAG Autoantibodies ELISA Citation: Sala E et al.; Acute neurological worsening after Rituximab treatment in patients with anti-MAG neuropathy. J Neurol Sci. 2014 Oct 15; 345(1-2):224-7. PMID:25115501  

Continue Reading

Prevalence, Specificity and Functionality of Anti-Ganglioside Antibodies in Neuropathy Associated with IgM Monoclonal Gammopathy

Anti-MAG Autoantibodies ELISA Citation: Stork AC et al.; Prevalence, specificity and functionality of anti-ganglioside antibodies in Neuropathy associated with IgM monoclonal gammopathy. J Neuroimmunol. 2014 Mar 15; 268(1-2): 89-94. PMID:24529728

Continue Reading

Polyneuropathy with Anti-sulfatide and Anti-MAG Antibodies: Clinical, Neurophysiological, Pathological Features and Response to Treatment

Anti-MAG Autoantibodies ELISA Citation: Campagnolo M et al.; Polyneuropathy with anti-sulfatide and anti-MAG antibodies: clinical, neurophysiological, pathological features and response to treatment. J Neuroimmunol. 2015 Apr 15; 281:1-4. PMID:25867460

Continue Reading

Heterogeneity of Polyneuropathy Associated with Anti-MAG Antibodies

Anti-MAG Autoantibodies ELISA Citation: Magy L et al.; Heterogeneity of Polyneuropathy Associated with Anti-MAG Antibodies; J Immunol Res. 2015;2015: 450391. doi: 10.1155/2015/450391. Epub 2015 May 6. PMID:26065001

Continue Reading

Fcγ Receptor IIIA Genotype is Associated with Rituximab Response in Anti-Myelin-Associated Glycoprotein Neuropathy

Anti-MAG Autoantibodies ELISA Citation: Stork AC et al.; Fcγ receptor IIIA genotype is associated with rituximab response in anti-myelin-associated glycoprotein neuropathy. J Neurol Neurosurg Psychiatry. 2014 Aug;85(8): 918-20.PMID:24487381

Continue Reading

Long-term Efficacy of Rituximab in IgM Anti-Myelin-Associated Glycoprotein Neuropathy: RIMAG Follow-up Study; Journal of the Peripheral Nervous System

Anti-MAG Autoantibodies ELISA Citation: Ferfoglia R I et al.; Long-term efficacy of rituximab in IgM anti-myelin-associated glycoprotein neuropathy: RIMAG follow-up study; Journal of the Peripheral Nervous System 21:10–14 (2016)PMID:26748872

Continue Reading

Classical and Lectin Complement Pathway Activity in Polyneuropathy Associated with IgM Monoclonal Gammopathy

Anti-MAG Autoantibodies ELISA Citations: Stork AC et al.; Classical and lectin complement pathway activity in polyneuropathy associated with IgM monoclonal gammopathy. J Neuroimmunol. 2016 Jan 15; 290:76-9. PMID:26711574

Continue Reading
Sign Up for BUHLMANN Updates!

Enter your email and stay on top of things,